DRUGABUSE SCIENCES INC
S-1/A, EX-27.1, 2000-08-23
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: DRUGABUSE SCIENCES INC, S-1/A, EX-23.3, 2000-08-23
Next: SOHU COM INC, 10-Q, 2000-08-23



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF OPERATIONS FOUND ON
PAGES F-3 AND F-4 OF THE COMPANY'S FORM S-1 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>                     <C>                     <C>                      <C>
<PERIOD-TYPE>                   YEAR                   YEAR                   YEAR                     YEAR
<FISCAL-YEAR-END>                          DEC-31-1997             DEC-31-1998             DEC-31-1999             DEC-31-2000
<PERIOD-START>                             JAN-01-1997             JAN-01-1998             JAN-01-1999             JAN-01-2000
<PERIOD-END>                               DEC-31-1997             DEC-31-1998             DEC-31-1999             JUN-30-2000
<CASH>                                               0               1,039,315              19,224,906              17,087,168
<SECURITIES>                                         0                       0                       0                       0
<RECEIVABLES>                                        0                 416,040               1,014,638               1,698,221
<ALLOWANCES>                                         0                       0                       0                       0
<INVENTORY>                                          0                       0                       0                       0
<CURRENT-ASSETS>                                     0               1,590,603              20,612,172              18,785,389
<PP&E>                                               0                 336,270                 396,935                 601,142
<DEPRECIATION>                                       0                (38,825)                (81,954)               (130,420)
<TOTAL-ASSETS>                                       0               1,997,048              21,036,632              19,282,920
<CURRENT-LIABILITIES>                                0                 591,468               1,180,909               2,738,473
<BONDS>                                              0                       0                       0                       0
                                0                       0                       0                       0
                                          0                   1,692                   4,861                   7,306
<COMMON>                                             0                   1,457                   2,721                   2,770
<OTHER-SE>                                           0                       0                       0                       0
<TOTAL-LIABILITY-AND-EQUITY>                         0               1,997,048              21,036,632              19,282,920
<SALES>                                              0                       0                       0                       0
<TOTAL-REVENUES>                                     0                 810,607               1,124,605                 981,828
<CGS>                                                0                       0                       0                       0
<TOTAL-COSTS>                                        0                       0                       0                       0
<OTHER-EXPENSES>                             1,382,412               2,083,553               7,603,658              10,657,208
<LOSS-PROVISION>                                     0                       0                       0                       0
<INTEREST-EXPENSE>                               3,065                  15,464                 122,496                  63,028
<INCOME-PRETAX>                            (1,300,163)             (1,192,343)             (6,228,002)             (9,032,380)
<INCOME-TAX>                                         0                       0                       0                       0
<INCOME-CONTINUING>                        (1,300,163)             (1,192,343)             (6,228,002)             (9,032,380)
<DISCONTINUED>                                       0                       0                       0                       0
<EXTRAORDINARY>                                      0                       0                       0                       0
<CHANGES>                                            0                       0                       0                       0
<NET-INCOME>                               (1,300,163)             (1,192,343)             (6,228,002)             (9,032,380)
<EPS-BASIC>                                     (0.61)                  (0.56)                  (7.45)                  (3.76)
<EPS-DILUTED>                                   (0.61)                  (0.56)                  (7.45)                  (3.76)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission